Azebiotics ApS: Financial statements 2020
CVR: 40503021
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Azebiotics ApS (CVR 40503021) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -186,108 and a net result of DKK -224,575. Equity in the 2020 report amounted to DKK -212,500.
- Gross Profit
- DKK -186,108
- Profit/Loss
- DKK -224,575
- Equity
- DKK -212,500
- Total Assets
- DKK 160,337
Official annual report
How creditworthy is Azebiotics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Azebiotics ApS has published its interim report for the period May 7, 2019 – December 31, 2019.
As of March 10, 2020, ECHOSTAR HOLDING ApS is registered as an owner of Azebiotics ApS with an ownership share of 5%.
As of March 10, 2020, Frederik Ammitzbøll Holding ApS is registered as an owner of Azebiotics ApS with an ownership share of 5%.
As of March 10, 2020, CORIS Holding ApS is registered as an owner of Azebiotics ApS with an ownership share of 20%.
As of March 10, 2020, LAJOVI Holding ApS is registered as an owner of Azebiotics ApS with an ownership share of 20%.
About Azebiotics ApS
Azebiotics ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Mikkel Bender. The company's owners include ECHOSTAR HOLDING ApS, MEVA HOLDING ApS and Frederik Ammitzbøll Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 67,779 and a net result of DKK 57,784 compared with DKK 176,367 the year before. Equity in the 2025 report amounted to DKK -288,030.